Analysen von Geoffrey Meacham
| 04.12.18 | Amgen Equal weight | Barclays Capital | |
| 19.10.18 | Pfizer Equal weight | Barclays Capital | |
| 27.08.18 | Pfizer Equal weight | Barclays Capital | |
| 23.08.18 | Pfizer Equal weight | Barclays Capital | |
| 05.04.18 | Pfizer Equal weight | Barclays Capital | |
| 03.05.17 | Pfizer overweight | Barclays Capital | |
| 16.03.17 | Pfizer overweight | Barclays Capital | |
| 29.11.16 | Pfizer overweight | Barclays Capital | |
|
Werbung
|
|||
| 05.01.16 | Pfizer Equal weight | Barclays Capital | |
| 20.08.12 | Gilead Sciences overweight | JP Morgan Chase & Co. | |
| 30.05.12 | Biogen neutral | JP Morgan Chase & Co. | |
| 24.02.12 | Gilead Sciences overweight | JP Morgan Chase & Co. | |
| 24.01.12 | Amgen neutral | JP Morgan Chase & Co. | |
| 24.01.12 | Viropharma neutral | JP Morgan Chase & Co. | |
| 17.08.11 | Gilead Sciences overweight | JP Morgan Chase & Co. | |
| 20.06.11 | InterMune overweight | JP Morgan Chase & Co. | |
| 17.05.11 | Amgen overweight | JP Morgan Chase & Co. | |
| 26.04.11 | Amgen overweight | JP Morgan Chase & Co. | |